Vectors Research Management, LLC Amgen Inc Transaction History

Vectors Research Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $8,074 - $8,985	35 Added 9.92%	388 $94,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $29,382 - $32,504	-134 Reduced 27.52%	353 $85,000
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $16,904 - $19,346	85 Added 21.14%	487 $110,000
Q1 2021 May 18, 2021	BUY	$221.91 - $258.6 $20,859 - $24,308	94 Added 30.52%	402 $100,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $57,340 - $68,282	265 Added 616.28%	308 $71,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $193,940 - $249,280	-1,025 Reduced 95.97%	43 $10,000
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $40,567 - $48,608	-233 Reduced 17.91%	1,068 $207,000
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $11,168 - $13,092	-67 Reduced 4.9%	1,301 $240,000
Q1 2019 Jul 15, 2019	SELL	$180.87 - $203.88 $23,513 - $26,504	-130 Reduced 8.68%	1,368 $260,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $66,008 - $77,052	370 Added 32.8%	1,498 $292,000
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $209,007 - $235,627	1,128 New	1,128 $209,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vectors Research Management, LLC with notifications on news.